Table 4 Main outcomes at the follow-up visits
From: Patients' perspectives on buprenorphine subcutaneous implant: a case series
Follow-up visit | Physical and psychological examination | COWS score and intervention |
|---|---|---|
24 h after the implant | • No distress reported • BP of 120/75 mmHg | • COWS = 0 • The patient reported no craving |
Day 7 after the implant | No distress reported | • COWS = 0 • The patient reported no craving |
Day 15 after the implant | Daytime drowsiness and diarrhoea reported | • COWS = 0 • The patient reported no craving |
1.5 months after the implant | No distress reported | • COWS = 0 • The patient reported no craving |
3 months after the implant | No distress reported | • COWS = 0 • The patient reported no craving |
4.5 months after the implant | No distress reported | • COWS = 0 • The patient reported no craving |
6 months after the implant | No distress reported | • COWS = 1, grading 1 • The patient reported no craving but was administered 2mg SL buprenorphine to alleviate her anxiety |
7 months after the implant | No distress reported | • COWS = 0 • The patient reported no craving but was administered 4mg SL buprenorphine to alleviate her anxiety |